3.2.2026 07:34:19 CET | Demant A/S |
Intern viden
Selskabsmeddelelse nr. 2026-03 3. februar 2026
Intern viden
Ændringer i Demants bestyrelse
Bestyrelsen påtænker at udpege Kristian Villumsen til ny formand for bestyrelsen
Thomas Hofman-Bang opstilles til valg til bestyrelsen på den kommende generalforsamling
Som tidligere udmeldt har den nuværende formand for Demants bestyrelse, Niels B. Christiansen, besluttet ikke at genopstille til bestyrelsen på den kommende generalforsamling den 5. marts 2026. Niels B. Christiansen har siddet i Demants bestyrelse i 17 år.
Bestyrelsen foreslår valg af Thomas Hofman-Bang. Han har international ledererfaring og en solid baggrund fra revisions- og produktionsvirksomheder. Han sidder i bestyrelserne for William Demant Fonden og William Demant Invest A/S, hvilket dermed opfylder Fondens vedtægtskrav om repræsentation i Demants bestyrelse.
Efter den ordinære generalforsamling påtænker bestyrelsen at udnævne Kristian Villumsen til ny formand. Kristian Villumsen er allerede medlem af Demants bestyrelse, hvor han har siddet siden 2021. Han har indgående kendskab til sundhedssektoren og omfattende international ledererfaring fra både direktions- og bestyrelsesarbejde.
“Vi sikrer kontinuitet i bestyrelsens ledelse ved at udnævne Kristian Villumsen som formand. Han bidrager med stor ledelseserfaring fra børsnoterede virksomheder og et indgående kendskab til Demant. Vi byder også Thomas Hofman-Bang velkommen, som kommer med relevante erfaringer, der vil styrke Demant i fremtiden,” siger Lars Nørby Johansen, formand for bestyrelsen i William Demant Fonden, som er hovedaktionær i Demant.
Kristian Villumsen, som forventes at blive formand for Demants bestyrelse, udtaler: “Jeg ser frem til at lede Demants bestyrelse og støtte virksomhedens strategi og formål om at forbedre livet for mennesker med høretab.”
De øvrige generalforsamlingsvalgte medlemmer af bestyrelsen, Niels Jacobsen, Sisse Fjelsted Rasmussen og Katrin Pucknat, genopstiller alle til bestyrelsen. Niels Jacobsen fortsætter som næstformand, en rolle han har haft siden 2017. Bestyrelsen i William Demant Fonden støtter de fremsatte forslag.
Kristian Villumsen har p.t. følgende roller:
Evido ApS, formand
UV Medico A/S, næstformand
Thomas Hofman-Bang har p.t. følgende roller:
Industriens Fond, CEO
William Demant Foundation, bestyrelsesmedlem
William Demant Invest A/S, bestyrelsesmedlem
Tryg A/S, bestyrelsesmedlem og formand for Revisions- og Risikokomitéerne
Fabriksejer, ingeniør Valdemar Selmer Trane og hustru, Elisa Tranes Fond, formand
Fonden CBS Academic Housing, formand
Foreningen Roskilde Festivalen, bestyrelsesmedlem
Den påtænkte udpegning af Kristian Villumsen til ny formand for bestyrelsen anses som intern viden iht. Markedsmisbrugsforordningen, artikel 17.
Yderligere information:
Søren Nielsen, koncernchef & adm. direktør
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Henrik Axel Lynge Buchter, Manager of External Communications
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Vedhæftninger
2026-03 Ændringer i Demants bestyrelse.pdf
3.2.2026 07:34:19 CET | Demant A/S |
Inside information
Company announcement no 2026-03 3 February 2026
Inside information
Changes to Demant’s Board of Directors
The Board intends to appoint Kristian Villumsen as new Chair of the Board
Thomas Hofman-Bang will be proposed for election to the Board at the upcoming annual general meeting
As previously announced, the current Chair of Demant’s Board of Directors, Niels B. Christiansen, has decided not to stand for re-election to the Board at the upcoming annual general meeting on 5 March 2026, after having served 17 years on the Board.
The Board will propose Thomas Hofman-Bang for election. He brings international leadership experience and a strong background from accounting and manufacturing companies. He serves on the boards of William Demant Foundation and William Demant Invest A/S, which will satisfy the Foundation charter requirement for representation on Demant’s Board.
After the annual general meeting, the Board intends to appoint Kristian Villumsen as new Chair. Kristian Villumsen is already a member of Demant’s Board, which he has been since 2021. He has deep insights into the healthcare industry and extensive international leadership experience from executive management and board positions.
“We will ensure continuity in Board leadership by appointing Kristian Villumsen as Chair. He brings strong listed-company leadership experience and extensive insight into Demant. We also welcome Thomas Hofman-Bang, who brings relevant experience that will support Demant going forward,” says Lars Nørby Johansen, Chair of the Board of Directors of William Demant Foundation, majority shareholder of Demant.
Kristian Villumsen, who is expected to become Chair of Demant’s Board of Directors, comments: “I look forward to leading Demant’s Board and supporting the company’s strategy and purpose of improving the lives of people with hearing loss.”
The other members of the Board elected at the annual general meeting, Niels Jacobsen, Sisse Fjelsted Rasmussen and Katrin Pucknat, will all stand for re-election. Niels Jacobsen will continue as Vice Chair, a role he has held since 2017. The Board of William Demant Foundation supports the proposals.
Kristian Villumsen currently holds the following positions:
Evido ApS, chair
UV Medico A/S, vice chair
Thomas Hofman-Bang currently holds the following positions:
Industriens Fond, CEO
William Demant Foundation, board member
William Demant Invest A/S, board member
Tryg A/S, board member and chair of the Audit and Risk Committees
Fabriksejer, ingeniør Valdemar Selmer Trane og hustru, Elisa Tranes Fond, chair
Fonden CBS Academic Housing, chair
Foreningen Roskilde Festivalen, board member
The intention to appoint Kristian Villumsen new Chair of the Board is deemed inside information pursuant to Article 17 of the Market Abuse Regulation.
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Henrik Axel Lynge Buchter, Manager of External Communications
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Attachments
2026-03 Changes to Demant’s Board of Directors.pdf
